TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

Phase Ib/II Study of Zanidatamab in Combination with Tislelizumab and Chemotherapy in First-Line HER2-Positive Gastric/Gastroesophageal Junction Adenocarcinoma.

Keun-Wook Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.